Patents by Inventor Daqing Ma

Daqing Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)
    Publication number: 20220112281
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Applicant: The Kennedy Trust for Rheumatology Research
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman, Jagdeep Nanchahal
  • Methods for reducing post-operative cognitive dysfunction (POCD)
    Patent number: 11220540
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: January 11, 2022
    Assignee: THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman, Jagdeep Nanchahal
  • COMPOSITIONS FOR ORGAN GRAFT PRESERVATION AND METHODS OF USE
    Publication number: 20200329698
    Abstract: The invention provides compositions, treatment means and protocols for induction of protective effects of organ grafts by administration of Dexmedetomidine, in combination with/without xenon or argon, in the conventional organ graft preservation solution storage solution. In one particular embodiment, the invention provides the activation of molecular pathways associated with reduction of oxidative stress and inhibition of regulated necrosis.
    Type: Application
    Filed: April 19, 2019
    Publication date: October 22, 2020
    Applicant: Nobilis Therapeutics, Inc.
    Inventors: Daqing MA, Hailin ZHAO, Andrew J.T. GEORGE, Qian CHEN, Jiateng GU, Jiaolin NING, Kaizhi LU
  • METHOD FOR PREVENTING OR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)
    Publication number: 20200123245
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: October 23, 2019
    Publication date: April 23, 2020
    Applicant: The Kennedy Trust for Rheumatology Research
    Inventors: Mervyn Maze, Marc Feldmann, Noccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman
  • Stimulation of Regenerative Processes and Factors by Noble Gases
    Publication number: 20190185896
    Abstract: The invention provides compositions, treatment means and protocols for induction of regenerative processes by administration of noble gases. In one particular embodiment the invention provides the stimulation of production of factors associated with augmentation of hematopoiesis, angiogenesis, and wound healing by exposure of cells, organs, or mammals to a noble gas. In a particular embodiment the invention provides the administration of argon as a noble gas capable of upregulating production of VEGF and angiopoietin.
    Type: Application
    Filed: December 19, 2017
    Publication date: June 20, 2019
    Applicant: NOBILIS THERAPEUTICS, INC.
    Inventors: Daqing Ma, Hailin Zhao, Kaizhi Lu, Jiaolin Ning, Jianteng Gu, Thomas Ichim, Vlad Bogin
  • Modulation of Amyloid Beta Toxicity and Processing By Xenon Gas
    Publication number: 20170348349
    Abstract: Disclosed are the unique and unexpected findings that xenon gas possesses the ability to directly inhibited amyloid beta associated toxicity, inhibit production of amyloid beta, and stimulate synthesis of soluble, free-form amyloid beta. The invention teaches the use of xenon gas, as well as various combinations of Noble Gases, for the prevention, amelioration, and treatment of Alzheimer's Disease and other pathologies associated with generation of insoluble aggregates containing amyloid beta.
    Type: Application
    Filed: June 7, 2017
    Publication date: December 7, 2017
    Inventors: Vlad Bogin, Thomas Ichim, Daqing Ma
  • METHODS
    Publication number: 20160333088
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: March 8, 2016
    Publication date: November 17, 2016
    Inventors: Mervyn Maze, Marc Feldman, Niccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman
  • Method for treatment of post operative cognitive dysfunction
    Patent number: 9308254
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: April 12, 2016
    Assignee: IMPERIAL INNOVATIONS LIMITED
    Inventors: Mervyn Maze, Marc Feldman, Niccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman
  • METHODS
    Publication number: 20130084299
    Abstract: The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.
    Type: Application
    Filed: February 17, 2011
    Publication date: April 4, 2013
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Mervyn Maze, Marc Feldman, Niccolo Terrando, Mario Cibelli, Daqing Ma, Michael Fertleman